

Bringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn More
Connecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MORE
Empowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn more
Working across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MORE
Delivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn more
Clinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn More
Harness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MORE
Pharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MORE
Primary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORE
Trusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MORE
Optimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MORE
A single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MORE
Connected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
"Unlocking Pharmaceutical Potential: The Growing Role of Thai Clinics
Read moreImproving human health needs innovative thinkers. Unleash your potential with us.
Search JobsDiscover how industry experts recognize IQVIA's impact across the Asia Pacific region.
LEARN MOREHealth Technology Assessment (HTA) has played a role in Indonesia’s health system since the launch of the National Health Insurance (JKN) in 2014, particularly in informing decisions about which health technologies should be or should not be covered under the benefits package.
Now, the government is taking a significant step forward. With the Ministry of Health’s launch of the “One Door, One-Standard HTA Business Process” in late 2024, Indonesia is moving toward a more coordinated, transparent, and systematic approach to the HTA process. This moment invites stakeholders across the healthcare ecosystem, from government, industry, providers, researchers, and civil society, to understand the emerging HTA landscape and how it may shape the way health technologies are evaluated, prioritized, and potentially made available in the years ahead.
This webinar is designed to provide a clear, accessible introduction to HTA’s evolution in Indonesia, its current direction, and what it could mean for different stakeholders. Participants will explore insights from global HTA systems that may offer useful lessons for Indonesia’s path forward as well.
Key highlights of the session include:
This is not a technical deep dive, but a foundational conversation, designed for anyone who wants to understand how HTA is being practiced, where it is headed, and why it could matter for the future of health innovation, equity, and sustainability in Indonesia.